ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGL Angle Plc

14.625
0.375 (2.63%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.375 2.63% 14.625 14.25 15.00 14.625 14.25 14.25 656,894 10:18:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 2.19M -20.13M -0.0624 -2.34 45.98M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14.25p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 322,641,668 shares in issue. The market capitalisation of Angle is £45.98 million. Angle has a price to earnings ratio (PE ratio) of -2.34.

Angle Share Discussion Threads

Showing 33951 to 33968 of 34200 messages
Chat Pages: 1368  1367  1366  1365  1364  1363  1362  1361  1360  1359  1358  1357  Older
DateSubjectAuthorDiscuss
06/7/2024
07:26
All you lot do is fight each other.He said this, he's such a....cos he said playing. Can't you all see what idiots you are. Think. Post about the company
muffster
05/7/2024
23:39
20p next week?Highly likely
atmysignal
05/7/2024
22:03
Fwiw 12p isn’t a target for me, it’s just a price I’d have bought in expectation of deals and spikes. If that doesn’t happen I won’t lose sleep and will be happy the company is going well. Equally, I think it’ll go lower than 12p around / after the next raise, because I think we all know that’ll come on the back of a major revenue miss.
adw198
05/7/2024
18:08
'Better luck next time'

I hope not.

htrocka2
05/7/2024
16:20
So much for the trolls 12p target

Better luck next time



sent from my iPhone

kryptonsnake
05/7/2024
13:13
Not another pump and dump.

New land hasn’t spent the last money already has he ?

Placing again ?

havinthelasttoast
05/7/2024
09:32
Perhaps we will see pressure on the NHS to reduce waiting lists and treatment times - Parsortix can make a major contribution to cancer diagnosis and treatment via non invasive blood tests and regular follow up to assess effectiveness of treatments - Angle need to be arranging a super urgent meeting with the new labour health minister to explain how 5his would help !!!!!!
millwallfan
04/7/2024
16:42
Spiked? At 14p?LOL
atmysignal
04/7/2024
13:53
Anyone get mug spiked ?
havinthelasttoast
04/7/2024
06:38
Thats some real intelligent analysis right there
paul planet earth 1
04/7/2024
06:16
More than 2 years since FDA approval and share price in the doldrums not far from its all time low. No wonder they couldn’t flog all the shares in the open offer. Will AGL ever make a profit?
davemac3
03/7/2024
21:17
@gooosed - relevant tweet when we consider:-• Germany's healthcare system is rightfully considered one of the BEST in the world. The country has one of the HIGHEST healthcare SPENDING levels in the WORLD, accounting for about 11% of GDP.• Germany launched a new 10 YEAR initiative - the "NATIONAL DECADE AGAINST CANCER".• This initiative is unique in that it BRINGS all TOGETHER who represent the diverse realms of politics, cancer RESEARCH, research FUNDING, health care, industry and civil society.• Will further STRENGTHEN oncological RESEARCH in Germany and EXPAND its international top position. It AIM's to develop NEW PERSONALISED TREATMENT methods and ADVANCE EXISTING treatments to enhance the quality of life and survival prospects of cancer patients. • The Federal Ministry of Education and Research WILL step UP its FUNDING for cancer RESEARCH. A first call for proposals will PROVIDE FUNDING to potentially PRACTICE-CHANGING CLINICAL TRIALS to verify and compare established methods of prevention, diagnosis and treatment with a view to enhancing patient benefit. Moreover, a FUNDING initiative will be launched to EXPLORE the great unresolved issues in cancer research.• The German Cancer Society has certified MORE THAN 1,000 centres across Germany and boasts considerable experience of quality assessment and development in oncological care. Https://www.dekade-gegen-krebs.de/SharedDocs/Downloads/de/files/19_ndk_gemeinsameerklaerung_eng_s2.pdf?__blob=publicationFile&v=2-OTHER considerations:• Germany belongs to the world's leading CLINICAL TRIAL LOCATIONS and - based on R&D INVESTMENT and patent application levels - is the LEADING PHARMACEUTICAL INNOVATION location in EUROPE.• The country is the largest exporter of medicinal products and ranks among the TOP pharmaceutical producers worldwide. In light of the GLOBAL NEED for PERSONALISED MEDICINE, Germany has also evolved into one of the MAIN suppliers of novel biopharmaceuticals.• MORE THAN 600 pharmaceutical companies are LOCATED in Germany.-5 LARGEST PHARMACEUTICAL companies in Germany:• Boehringer• Bayer• Merck• Novartis• Roche-DISTRIBUTOR:• HiSS DiagnosticsHttps://hiss-dx.de/en/• Parsortix Instrument:Https://hiss-dx.de/en/products/instruments/laboratory-equipment/2234/parsortix-instrument• Portrait+ CTC Staining KitHttps://hiss-dx.de/en/products/diagnostics-research-solutions/oncology/breast-cancer/2545/portrait-ctc-staining-kit?number=POR-AK-010N-
5oletrader
03/7/2024
19:40
jelenko - thanks in advance for any feedback & here's hoping it is worth your time & effort.
gooosed
03/7/2024
10:30
Waiting for the AZ outcome...
htrocka2
03/7/2024
10:11
I am planning on attending
jelenko
03/7/2024
09:04
Is anyone attending the AGM & able to provide feedback ? There is a business update scheduled after the formalities but the live events are often more insightful.
gooosed
02/7/2024
15:42
Artios have big backers

Apr 7, 2021
businessweekly.co.uk — Artios clinches minimum $1.5bn from Novartis for cancer assault


Apr 7, 2021
FierceBiotech — Novartis taps Artios for targets to enhance radioligand drugs
Funding Round

Dec 3, 2020
Artios Pharma raised $30,000,000 / Series Unknown from Darmstadt and Merck
Discover more funding rounds

Dec 3, 2020
FierceBiotech — Merck KGaA pens major cancer drugs biobucks pact with DNA damage biotech Artios Pharma

thiopia
02/7/2024
13:21
ToastyRemember to flush afterwards
countbasie1
Chat Pages: 1368  1367  1366  1365  1364  1363  1362  1361  1360  1359  1358  1357  Older

Your Recent History

Delayed Upgrade Clock